Maxipaedia & Maxoniq the founder story of health tech commercialisation
The Five year Startup. What’s next and what does it take to translate medical experience, research and innovation into a commercial product? In this interactive Q&A session Dr George Dimitroulis will officially launch Maxipaedia, the next step in the global commercialisation journey of Maxoniq. We will hear the founder story, built on a solid foundation as a specialist Maxillofacial consultant with nearly 30 years experience, dozens of industry publications, 6 books, 26 patents pending or approved and Australis first 3D printed TMJ medical device.
This interactive session is for those that have a clinical background and are interested to learn how to direct their own passions into a commercial enterprise. This interactive discussion will be facilitated by Marc Niemes from KontentLabs.
MAXONIQ, established in 2016, has a growing portfolio of bespoke medical devices for oral and maxillofacial applications. Headquartered in Melbourne, MAXONIQ is an Australian owned company with a goal to be the world leader in developing new custom-made surgical products and devices that will become game-changers in oral and maxillofacial surgery. Prior to March 2021, MAXONIQ was known as OMX Solutions.